Synergistic immunosuppressive effects of rosmarinic acid and rapamycin in vitro and in vivo1
Authors:
- Yun-Gyoung HurYHYun-Gyoung Hur
- Mi-Ae KangMKMi-Ae Kang
- Jihyun LeeJLJihyun Lee
- Curie AhnCACurie Ahn
- Jonghwa WonJWJonghwa Won
- 27 May 2003
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 75 (10) , 1758-1760
Abstract
We previously demonstrated that rosmarinic acid (RosA) inhibits T-cell antigen receptor-induced T-cell activation and proliferation. In this study, we evaluated the ability of RosA alone and in conjunction with currently used immunosuppressive drugs to inhibit in vitro splenic T-cell proliferation and prolong skin graft survival in vivo. Mouse splenic T-cell proliferation assays were performed in the presence of RosA alone or in combination with cyclosporine, rapamycin (Rapa), or prednisone (Pred). The in vivo synergistic efficacy of RosA and Rapa was evaluated in the mouse skin allograft model. RosA combined with Rapa or prednisone synergistically inhibited splenic T-cell proliferation, whereas the combination of RosA and cyclosporine additively inhibited T-cell proliferation. The combination of RosA and Rapa synergistically prolonged allograft survival. We conclude that the combination of RosA and Rapa promotes immunosuppressive effects.Keywords
This publication has 8 references indexed in Scilit:
- Rosmarinic acid inhibits TCR‐induced T cell activation and proliferation in an Lck‐dependent mannerEuropean Journal of Immunology, 2003
- Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycinBlood, 2002
- THE TWO-SIGNAL MODEL OF T-CELL ACTIVATION AFTER 30 YEARSTransplantation, 2002
- RAPAMYCIN: CLINICAL RESULTS AND FUTURE OPPORTUNITIES1Transplantation, 2001
- Immunosuppressive drugs: the first 50 years and a glance forwardImmunopharmacology, 2000
- Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn.Phytomedicine, 2000
- Cyclosporine induces cancer progression by a cell-autonomous mechanismNature, 1999
- Rosmarinic acid: A new inhibitor of complement C3-convertase with anti-inflammatory activityInternational Journal of Immunopharmacology, 1988